Subscribe: Lymphoma / Leukemia / Myeloma News From Medical News Today
http://www.medicalnewstoday.com/rss/lymphoma-leukemia.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
acute myeloid  acute  blood cancer  blood  cancer  cells  leukemia  lymphoma  myeloid leukemia  myeloid  new  patients  treatment 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Lymphoma / Leukemia / Myeloma News From Medical News Today

Lymphoma / Leukemia / Myeloma News From Medical News Today



Leukemia is a cancer of the blood cells, usually affecting the white blood cells, which causes these cells to not work properly. There are four main types of leukemia. Lymphoma is a type of cancer that originates in the lymphatic system. There are two mai



Copyright: Copyright 2017 Medical News Today
 



Leukemia: Mushroom protein could be used in future treatments

Sun, 13 Aug 2017 00:00:00 PDT

A protein found in the edible mushroom commonly known as "shaggy ink cap" has the potential to kill leukemia T cells, a new study suggests.



Drug hope for acute myeloid leukaemia

Fri, 11 Aug 2017 00:00:00 PDT

A new drug that strips cancer cells of their "immortality" could help to treat patients suffering from one of the most aggressive forms of leukaemia.



FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

Fri, 04 Aug 2017 06:00:00 PDT

The U.S. Food and Drug Administration has approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with...



Leukemia breakthrough: Blood molecule key to treating AML

Fri, 04 Aug 2017 00:00:00 PDT

Heme, a chemical structure found in hemoglobin, is key to treating acute myeloid leukemia, an aggressive form of blood cancer, researchers have discovered.



FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

Wed, 02 Aug 2017 06:00:00 PDT

The U.S. Food and Drug Administration has approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic...



Cell mechanism discovery could lead to 'fundamental' change in leukemia treatment

Mon, 31 Jul 2017 00:00:00 PDT

Researchers have identified a new cell mechanism that could lead to a fundamental change in the diagnosis and treatment of leukaemia.



Scientists make breakthrough in reversing treatment resistance in blood cancer patients

Wed, 19 Jul 2017 00:00:00 PDT

Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.



CAR T-cell therapy for leukemia leads to remissions in clinical trial

Wed, 19 Jul 2017 00:00:00 PDT

Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric...



Human antibody bolsters cancer drug performance

Sat, 01 Jul 2017 00:00:00 PDT

Some patients do not respond to the cancer drug rituximab, but breaking research finds that the addition of a human antibody reduces this resistance.



The gene behind follicular lymphoma

Thu, 29 Jun 2017 06:00:00 PDT

EPFL scientists have discovered an important gene whose loss lies behind follicular lymphoma, an incurable cancer.



New antibody uses one-two punch to potentially treat blood cancers

Tue, 27 Jun 2017 00:00:00 PDT

Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the nurturing bone marrow environment into the peripheral...



Protein network signals found to drive myeloid leukemias

Fri, 16 Jun 2017 00:00:00 PDT

Researchers have uncovered how mutations in a protein network drive several high-risk leukemias, offering new prospects for novel therapies.



Precision therapy enasidenib effective in treating deadly form of leukemia

Mon, 12 Jun 2017 00:00:00 PDT

Some patients with relapsed or treatment-resistant acute myeloid leukemia, a form of blood cancer for which there are few treatments, may achieve remission with an experimental targeted therapy...



Cannabinoids and chemotherapy in combination kill cancer cells

Wed, 07 Jun 2017 00:00:00 PDT

Certain chemicals in cannabis have a potent leukemia-fighting prowess. New research shows that the key to killing cancer is the combination and order.



Study leads to breakthrough in better understanding acute myeloid leukemia

Wed, 24 May 2017 09:00:00 PDT

A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.



New test more effective at predicting survival in blood cancer patients

Thu, 11 May 2017 00:00:00 PDT

Technology that can detect the length of small DNA structures in cancer cells could hold the key to predicting the outcome of patients with two different types of blood cancer.



Hodgkin lymphoma survivors have more severe coronary artery disease post chest irradiation

Tue, 09 May 2017 00:00:00 PDT

Findings support argument for coronary artery disease screening after irradiationHodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to...



FDA approves new combination treatment for acute myeloid leukemia

Tue, 02 May 2017 06:00:00 PDT

The U.S. Food and Drug Administration has approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation...



'Outstanding' results announced from new blood cancer study

Tue, 02 May 2017 00:00:00 PDT

Scientists have described new results of a blood cancer study as 'outstanding' in tackling previously untreatable forms of chronic lymphocytic leukaemia (CLL).



Scientists create leukaemia online tool to aid global search for cure

Mon, 01 May 2017 00:00:00 PDT

Finding a cure for a rare type of blood cancer could be accelerated by a new virtual platform that allows researchers easy access to data from patient samples generated by laboratories around the...



New study offers hope for more effective treatment of leukemia

Mon, 17 Apr 2017 00:00:00 PDT

The discovery of a protein signature that is highly predictive of leukemia could lead to novel treatments of the leading childhood cancer, according to new study showing that competition among...



Global inequalities in survival for childhood leukaemia persist, highlighting need for better care

Thu, 13 Apr 2017 00:00:00 PDT

Although global inequalities in survival from childhood leukaemia have narrowed, they still persist with five-year survival in some countries nearly twice as high as in others for children...



Method may help myeloma patients avoid painful biopsies

Thu, 06 Apr 2017 06:00:00 PDT

Multiple myeloma is a cancer of the plasma cells, which are white blood cells produced in bone marrow that churn out antibodies to help fight infection.



AML study correlates gene mutations with 34 disease subgroups

Thu, 23 Mar 2017 06:00:00 PDT

A large, new study of adults with acute myeloid leukemia (AML) correlates 80 cancer-related gene mutations with five subtypes of AML, which are defined by the presence of specific chromosomal...



Hodgkin lymphoma survivors at high risk of second cancers

Tue, 14 Mar 2017 06:00:00 PDT

Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.